Histiocytic sarcoma arising from clonally related mantle cell lymphoma

J Clin Oncol. 2012 Feb 10;30(5):e49-53. doi: 10.1200/JCO.2011.38.8553. Epub 2011 Dec 19.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Axilla
  • Brain Neoplasms / secondary
  • CCAAT-Enhancer-Binding Protein-beta / metabolism*
  • Disease Progression
  • Down-Regulation
  • Female
  • Gene Expression Regulation, Neoplastic
  • Groin
  • Histiocytic Sarcoma / diagnosis*
  • Histiocytic Sarcoma / etiology*
  • Histiocytic Sarcoma / metabolism
  • Histiocytic Sarcoma / pathology
  • Histiocytic Sarcoma / therapy
  • Humans
  • Hysterectomy
  • Immunohistochemistry
  • Immunophenotyping
  • Lymph Node Excision
  • Lymph Nodes / pathology*
  • Lymphoma, Mantle-Cell / complications*
  • Lymphoma, Mantle-Cell / diagnosis*
  • Lymphoma, Mantle-Cell / metabolism
  • Lymphoma, Mantle-Cell / pathology
  • Lymphoma, Mantle-Cell / therapy
  • Middle Aged
  • PAX5 Transcription Factor / metabolism*
  • Pelvic Neoplasms / secondary
  • Pelvic Neoplasms / therapy
  • Retroperitoneal Neoplasms / secondary
  • Retroperitoneal Neoplasms / therapy
  • Stem Cell Transplantation
  • Transplantation, Autologous
  • Transplantation, Homologous
  • Up-Regulation
  • Uterine Neoplasms / secondary
  • Uterine Neoplasms / therapy

Substances

  • CCAAT-Enhancer-Binding Protein-beta
  • PAX5 Transcription Factor
  • PAX5 protein, human